Indirubin alleviates CCl4-induced liver fibrosis by regulation of TGF-β-mediated signaling pathways
Objective(s): Liver fibrosis is a common liver disease caused by chronic liver damage. However, there are currently no approved drugs available to treat it. Therefore, the therapeutic effect of indirubin on liver fibrosis was evaluated. This study investigated the protective effect and related molec...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Mashhad University of Medical Sciences
2023-09-01
|
| Rangatū: | Iranian Journal of Basic Medical Sciences |
| Ngā marau: | |
| Urunga tuihono: | https://ijbms.mums.ac.ir/article_22466_cf60eebb92ce85618e0eecc20197e6b9.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|